Véronique joined DGr Pharma in December 2018 as Project Coordinator and Quality Manager. In her role as Quality Manager, she is responsible for the full implementation and maintenance of DGr Pharma’s GxP Quality Management System and she supports external clients as QA consultant.
Before joining DGr Pharma, she worked for nearly 17 years at Kinesis Pharma where she started as monitoring scientist bioanalysis. Besides her bioanalytical monitoring activities, she specialized in non-clinical PK and as Principal Investigator she was responsible for the execution and reporting of Non-Clinical pharmaco- and toxicokinetic GLP multi-site studies.
Over the years, Véronique got engaged in Quality Assurance and joined the Kinesis Pharma QA department where she was involved in planning and execution of the internal (facility & system) audit program and hosted several client audits and regulatory inspections.
During 2017-2018, she was project lead for the implementation of a new company-wide CAPA management system.
As part of her QA role, she also supported external companies with project management of postal PV license partner audits, with CAPA and TrackWise record management and acting as GLP QA officer.
In 1998, Véronique obtained her B.Sc. degree in Clinical Chemistry. The subject of her thesis, performed at the Department of Genetic and in vitro Toxicology of Janssen, was “Evaluation of alternative assays for the detection of DNA damage (Vitotox, Comet, Amax, Ames).” Hereafter she started her professional career at Janssen; initially in the in vitro Pharmacokinetics group. Thereafter, she joined the Bioanalytical Department where she was responsible for departmental planning and electronic sample management.